BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
PRKCA
,
glucose metabolic process
,
Diabetes mellitus
,
Liver
,
Acetaminophen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Agomelatine
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Long-term maintenance therapy of depressive disorders with antidepressants: experience of using agom…
Clinical experience in using agomelatin (valdoxan) in the neurological practice].
Agomelatine: a novel antidepressant.
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open l…
Possibilities of preventive treatment of migraine with the MT1- and MT2 agonist and 5-HT2с receptor …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Prophylactic Effects of Agomelatine for Poststroke Depression
Agomelatine in Depressed Patients With Fibromyalgia
Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)
Agomelatine Augmentation Added to SSRIs or SNRIs for Depression
the Efficacy and Safety of Agomelatine in the Patients With Parkinson's Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ